Estelle Guiheneuf 

Estelle Guiheneuf

Interim Head of Oncology

Since 2019, Estelle has joined the TFS HealthScience team, bringing with her 21 years of clinical trials experience, from Phase I to Phase III, in an international environment. For 17 years, she specialized in Phase I trials for solid tumors. For the past 7 years, she is dedicated to early phases trials, with a strong understanding of all aspects and the challenges and flexibility required with cohort managements, developing a close collaboration with the early phases Investigators in many countries.  She brings passion to her oncology team, with a strong focus on delivering successful studies. 

Learn more about our mission and values, and meet our executive leadership team.

About TFS

Thought Leadership Written by Estelle Guiheneuf

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to KnowArticle

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Revolutionizing-Oncology-Trials-The-Power-of-Immunotherapy-and-Precision-Medicine-in-Cancer-Research_featured
Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer ResearchArticle

Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research